CTRI/2019/10/021758
Not yet recruiting
Phase 3
The Indian Paediatric Oncology Group collaborative multicentre treatment protocol for children and adolescents with relapsed acute lymphoblastic leukaemia (InPOG ALL R1) - InPOG ALL R1
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
- Sponsor
- Tata Medical Center
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Untreated first relapse of acute lymphoblastic leukaemia
- •2\.Availability of clinical and laboratory information necessary for risk stratification
- •3\.Consent to be treated on the study protocol
Exclusion Criteria
- •Inability to be treated with intensive chemotherapy on account of
- •1\.unsuitable clinical status
- •2\.prior adverse or dose\-limiting treatment toxicity
- •3\.prior maximum cumulative drug exposure; and/or
- •4\.unsatisfactory organ function
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Pediatric Oncology and Palliative Medicine Team Development Working Package 1All life-threatening hematoma-oncological diseases in childhoodDRKS00027339KGM - Universitätsklinikum Giessen und Marburg GmbH5,000
Active, not recruiting
Not Applicable
A Children’s Oncology Group pilot study for the treatment of very high risk acute lymphoblastic leukemia in children and adolescentsAcute lymphoblastic leukemiaMedDRA version: 14.1Level: LLTClassification code 10024338Term: Leukemia lymphoblastic acuteSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001477-82-Outside-EU/EEAChildren's Oncology Group (COG)160
Completed
Not Applicable
Pilot testing of a decision aid for nutrition support in paediatric oncology.Malnutrition in paediatric oncologyDiet and Nutrition - Other diet and nutrition disordersCancer - Any cancerACTRN12615001082594Behavioural Sciences Unit, Sydney Children's Hospital40
Recruiting
Not Applicable
Identifying the critically ill paediatric oncology patientpaediatric cancerNL-OMON24811KiKa grant number 2871,500
Active, not recruiting
Phase 1
Paediatric Hepatic International Tumour TrialHepatoblastoma and Hepatocellular Carcinoma.MedDRA version: 20.0Level: PTClassification code 10062001Term: HepatoblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-002828-85-PLMedical University of Gdansk60